Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002016704 | SCV002301339 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002346293 | SCV002651262 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2021-04-26 | criteria provided, single submitter | clinical testing | The p.H1918R variant (also known as c.5753A>G), located in coding exon 46 of the FBN1 gene, results from an A to G substitution at nucleotide position 5753. The histidine at codon 1918 is replaced by arginine, an amino acid with highly similar properties, and is located in the cbEGF-like #28 domain. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002486696 | SCV002776648 | uncertain significance | Ectopia lentis 1, isolated, autosomal dominant; Marfan syndrome; MASS syndrome; Stiff skin syndrome; Weill-Marchesani syndrome 2, dominant; Acromicric dysplasia; Geleophysic dysplasia 2; Progeroid and marfanoid aspect-lipodystrophy syndrome | 2021-10-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004011136 | SCV004825649 | uncertain significance | Marfan syndrome | 2023-05-31 | criteria provided, single submitter | clinical testing |